These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease. Fu J; Lai X; Huang Y; Bao T; Yang J; Chen S; Chen X; Shang H BMC Neurol; 2023 Feb; 23(1):66. PubMed ID: 36774494 [TBL] [Abstract][Full Text] [Related]
4. Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer's Disease. González-Sánchez M; Díaz T; Pascual C; Antequera D; Herrero-San Martín A; Llamas-Velasco S; Villarejo-Galende A; Bartolome F; Carro E Mol Neurobiol; 2018 Dec; 55(12):8815-8825. PubMed ID: 29603091 [TBL] [Abstract][Full Text] [Related]
9. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
10. Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer's Disease Platelets. Sarno TA; Talib LL; Joaquim HP; Bram JM; Gattaz WF; Forlenza OV J Alzheimers Dis; 2017; 55(4):1445-1451. PubMed ID: 27858713 [TBL] [Abstract][Full Text] [Related]
12. Peripheral inflammatory biomarkers of Alzheimer's disease: the role of platelets. Casoli T; Di Stefano G; Balietti M; Solazzi M; Giorgetti B; Fattoretti P Biogerontology; 2010 Oct; 11(5):627-33. PubMed ID: 20454929 [TBL] [Abstract][Full Text] [Related]
13. Platelets and Alzheimer's disease: Potential of APP as a biomarker. Evin G; Li QX World J Psychiatry; 2012 Dec; 2(6):102-13. PubMed ID: 24175176 [TBL] [Abstract][Full Text] [Related]
14. The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. Cavedo E; Lista S; Khachaturian Z; Aisen P; Amouyel P; Herholz K; Jack CR; Sperling R; Cummings J; Blennow K; O'Bryant S; Frisoni GB; Khachaturian A; Kivipelto M; Klunk W; Broich K; Andrieu S; de Schotten MT; Mangin JF; Lammertsma AA; Johnson K; Teipel S; Drzezga A; Bokde A; Colliot O; Bakardjian H; Zetterberg H; Dubois B; Vellas B; Schneider LS; Hampel H J Prev Alzheimers Dis; 2014 Dec; 1(3):181-202. PubMed ID: 26478889 [TBL] [Abstract][Full Text] [Related]
15. Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease. Gibson GE; Huang HM Front Biosci; 2002 Apr; 7():d1007-15. PubMed ID: 11897553 [TBL] [Abstract][Full Text] [Related]
16. The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation. Elsworthy RJ; Aldred S Exp Gerontol; 2020 Apr; 132():110838. PubMed ID: 31981682 [TBL] [Abstract][Full Text] [Related]
17. Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function. Kettunen P; Larsson S; Holmgren S; Olsson S; Minthon L; Zetterberg H; Blennow K; Nilsson S; Sjölander A J Alzheimers Dis; 2015; 44(4):1313-22. PubMed ID: 25420549 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of fluid biomarkers in Alzheimer's Disease. Lewczuk P; Łukaszewicz-Zając M; Mroczko P; Kornhuber J Pharmacol Rep; 2020 Jun; 72(3):528-542. PubMed ID: 32385624 [TBL] [Abstract][Full Text] [Related]
19. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings. Blennow K; Zetterberg H Prog Mol Biol Transl Sci; 2019; 168():3-23. PubMed ID: 31699324 [TBL] [Abstract][Full Text] [Related]
20. Platelets, lymphocytes and erythrocytes from Alzheimer's disease patients: the quest for blood cell-based biomarkers. Pluta R; Ułamek-Kozioł M; Januszewski S; Czuczwar SJ Folia Neuropathol; 2018; 56(1):14-20. PubMed ID: 29663736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]